Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)
Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%
Zimmer Biomet total assets
Total assets on the balance sheet at the end of each period.
Zimmer Biomet's total assets was $22.80B at Jun 30, 2026. For fiscal 2025 it was $23.09B, up 8.1% from the year before. Over ten years it grew -1.6% a year on average. The highest annual figure on record is $27.16B in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.09B | +8.1% |
| FY2024 | Dec 31, 2024 | $21.37B | -0.6% |
| FY2023 | Dec 31, 2023 | $21.50B | +2.0% |
| FY2022 | Dec 31, 2022 | $21.07B | -10.2% |
| FY2021 | Dec 31, 2021 | $23.46B | -3.9% |
| FY2020 | Dec 31, 2020 | $24.42B | -0.9% |
| FY2019 | Dec 31, 2019 | $24.64B | +2.1% |
| FY2018 | Dec 31, 2018 | $24.13B | -7.3% |
| FY2017 | Dec 31, 2017 | $26.01B | -2.5% |
| FY2016 | Dec 31, 2016 | $26.68B | -1.8% |
| FY2015 | Dec 31, 2015 | $27.16B | +181.2% |
| FY2014 | Dec 31, 2014 | $9.66B | +0.7% |
| FY2013 | Dec 31, 2013 | $9.60B | +6.5% |
| FY2012 | Dec 31, 2012 | $9.01B | +5.8% |
| FY2011 | Dec 31, 2011 | $8.52B | +6.4% |
| FY2010 | Dec 31, 2010 | $8.00B | +2.8% |
| FY2009 | Dec 31, 2009 | $7.79B | +7.5% |
| FY2008 | Dec 31, 2008 | $7.24B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.80B | -0.3% |
| Q1 FY2026 | Mar 31, 2026 | $22.72B | +2.4% |
| Q4 FY2025 | Dec 31, 2025 | $23.09B | +8.1% |
| Q3 FY2025 | Sep 30, 2025 | $23.49B | +8.1% |
| Q2 FY2025 | Jun 30, 2025 | $22.87B | +6.3% |
| Q1 FY2025 | Mar 31, 2025 | $22.18B | +3.4% |
| Q4 FY2024 | Dec 31, 2024 | $21.37B | -0.6% |
| Q3 FY2024 | Sep 30, 2024 | $21.72B | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | $21.52B | +1.1% |
| Q1 FY2024 | Mar 31, 2024 | $21.45B | +1.0% |
| Q4 FY2023 | Dec 31, 2023 | $21.50B | +2.0% |
| Q3 FY2023 | Sep 30, 2023 | $21.22B | -0.5% |
| Q2 FY2023 | Jun 30, 2023 | $21.29B | -0.7% |
| Q1 FY2023 | Mar 31, 2023 | $21.24B | -1.7% |
| Q4 FY2022 | Dec 31, 2022 | $21.07B | -10.2% |
| Q3 FY2022 | Sep 30, 2022 | $21.33B | -11.1% |
| Q2 FY2022 | Jun 30, 2022 | $21.45B | -11.4% |
| Q1 FY2022 | Mar 31, 2022 | $21.62B | -10.0% |
| Q4 FY2021 | Dec 31, 2021 | $23.46B | -3.9% |
| Q3 FY2021 | Sep 30, 2021 | $24.01B | -0.1% |
| Q2 FY2021 | Jun 30, 2021 | $24.22B | +2.4% |
| Q1 FY2021 | Mar 31, 2021 | $24.03B | -5.8% |
| Q4 FY2020 | Dec 31, 2020 | $24.42B | -0.9% |
| Q3 FY2020 | Sep 30, 2020 | $24.03B | -1.2% |
| Q2 FY2020 | Jun 30, 2020 | $23.65B | -2.3% |
| Q1 FY2020 | Mar 31, 2020 | $25.51B | +5.0% |
| Q4 FY2019 | Dec 31, 2019 | $24.64B | +2.1% |
| Q3 FY2019 | Sep 30, 2019 | $24.32B | -4.2% |
| Q2 FY2019 | Jun 30, 2019 | $24.21B | -5.0% |
| Q1 FY2019 | Mar 31, 2019 | $24.29B | -10.6% |
| Q4 FY2018 | Dec 31, 2018 | $24.13B | -7.3% |
| Q3 FY2018 | Sep 30, 2018 | $25.38B | -3.9% |
| Q2 FY2018 | Jun 30, 2018 | $25.49B | -3.7% |
| Q1 FY2018 | Mar 31, 2018 | $27.18B | +0.7% |
| Q4 FY2017 | Dec 31, 2017 | $26.01B | -2.5% |
| Q3 FY2017 | Sep 30, 2017 | $26.42B | -2.3% |
| Q2 FY2017 | Jun 30, 2017 | $26.46B | – |
| Q1 FY2017 | Mar 31, 2017 | $26.99B | – |
| Q4 FY2016 | Dec 31, 2016 | $26.68B | – |
| Q3 FY2016 | Sep 30, 2016 | $27.04B | – |
See a number that looks wrong?